Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study
Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study. // ESMO Real World Data and Digital Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2949820126000962?dgcid=rss_sd_all
Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study. ESMO Real World Data and Digital Oncology. https://www.sciencedirect.com/science/article/pii/S2949820126000962?dgcid=rss_sd_all
“Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study.” ESMO Real World Data and Digital Oncology.
@article{article44835,
title = {Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study},
journal = {ESMO Real World Data and Digital Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2949820126000962?dgcid=rss_sd_all}
}